Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.
Press releases published on September 12, 2025
Lucrumia Announces Major European Expansion with Enhanced Transparency Initiatives and Independent Third-Party Verification Program
GlobeNewswire
·
September 12, 2025
DENVER, CO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Lucrumia Crypto Group Ltd, the U.S.-registered global cryptocurrency exchange, today announced a comprehensive European market expansion alongside the launch of its industry-leading Transparency Initiative …
Avicanna Announces Change in CFO
GlobeNewswire
·
September 12, 2025
TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based …
Enovix Korea Named 2025 Best Workplace for Job Creation in Korea by Ministry of Employment and Labor
GlobeNewswire
·
September 12, 2025
FREMONT, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a leader in advanced silicon battery technology, announced today that Enovix Korea has been honored with the prestigious 2025 Best Workplaces of …
Altai Announces Dismissal of Its Claim by Quebec Court
GlobeNewswire
·
September 12, 2025
TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that, further to the Company’s news release dated September 5, 2025, in connection with the Company’s claim filed in the Superior Court …
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 12, 2025
CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 12, 2025
DURHAM, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on September 12, 2025, to one …
Vor Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
GlobeNewswire
·
September 12, 2025
CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in a fireside chat and host virtual 1x1 investor …
4DMT Announces New Employment Inducement Grants
GlobeNewswire
·
September 12, 2025
EMERYVILLE, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …
ESET Research discovers UEFI-compatible HybridPetya ransomware capable of Secure Boot bypass
GlobeNewswire
·
September 12, 2025
ESET Research has discovered new ransomware samples, which it has named HybridPetya, resembling the infamous Petya/NotPetya malware. They were uploaded to VirusTotal in February 2025. HybridPetya encrypts the Master File Table, which contains important …
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
GlobeNewswire
·
September 12, 2025
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, …
AlliAI Announces New Features That Change the Game For Users
GlobeNewswire
·
September 12, 2025
Bakersfield, CA, Sept. 12, 2025 (GLOBE NEWSWIRE) -- AlliAl has announced the latest evolution of its platform with new features, designed to simplify, anticipate, and elevate every aspect of your life. The modern world demands solutions that don’t just …
クラウデラ (Cloudera)、IDC APACマーケットスケープ (IDC APAC MarketScape) のユニファイドAIプラットフォーム 2025 ベンダーアセスメント (Unified AI Platforms 2025 Vendor Assessment) においてリーダーに認定
GlobeNewswire
·
September 12, 2025
シンガポール発 , Sept. 13, 2025 (GLOBE NEWSWIRE) -- あらゆる場所のデータにAIを提供する唯一の企業であるクラウデラは本日、IDC APACマーケットスケープによるユニファイドAIプラットフォーム 2025 ベンダーアセスメントにおいて、リーダーに認定されたことを発表した。 IDCは、エンタープライズグレードのガバナンス、セキュリティ、運用機能とともに、最新の生成AIおよびエージェント型ワークフローを統合する包括的なプラットフォームを提供するクラウデラの能力を評価した。 …
Cloudera Diiktiraf sebagai Peneraju dalam Penilaian Vendor IDC APAC MarketScape bagi Platform AI Bersatu 2025
GlobeNewswire
·
September 12, 2025
SINGAPURA, Sept. 13, 2025 (GLOBE NEWSWIRE) -- Cloudera, satu-satunya syarikat yang membawa AI kepada data di mana-mana sahaja, hari ini mengumumkan bahawa ia telah diiktiraf sebagai Peneraju dalam penilaian vendor IDC APAC MarketScape bagi Platform AI …
Cloudera 獲 IDC 認可為 2025 年亞太區統一 AI 平台供應商評估的領導先鋒
GlobeNewswire
·
September 12, 2025
新加坡, Sept. 13, 2025 (GLOBE NEWSWIRE) -- Cloudera 是唯一讓 AI 無處不在地融入數據的企業，今天宣佈在《IDC MarketScape：2025 年亞太區統一 AI 平台供應商評估》( IDC APAC MarketScape for Unified AI Platforms 2025 Vendor Assessment) 報告中獲評為領導先鋒。 IDC 重點指出 Cloudera 能夠提供全方位平台，將最新的生成式 AI …
Cloudera, IDC APAC MarketScape 통합 AI 플랫폼 2025 벤더 평가에서 리더로 선정
GlobeNewswire
·
September 12, 2025
싱가포르, Sept. 13, 2025 (GLOBE NEWSWIRE) -- IDC 데이터 환경에 관계없이 AI를 적용하는 유일 기업인 Cloudera가 IDC APAC MarketScape 통합 AI 플랫폼 2025 벤더 평가에서 리더 (Leader)로 선정되었다고 오늘 발표했다. IDC는 클라우데라가 최신 생성형 AI와 에이전틱(Agentic) 워크플로우를 엔터프라이즈급 거버넌스, 보안, 운영 기능과 통합해 종합적인 플랫폼을 제공할 수 있는 역량을 높이 …
Cloudera 在 2025 年度《IDC MarketScape 亚太区统一 AI 平台供应商评估》报告中被评为领导者
GlobeNewswire
·
September 12, 2025
新加坡, Sept. 13, 2025 (GLOBE NEWSWIRE) -- 全球唯一将 AI 应用于各类数据的公司 Cloudera 今日宣布，在 2025 年《IDC MarketScape 亚太区统一 AI 平台供应商评估》报告中被评为领导者。 IDC 强调了 Cloudera 在提供综合性平台方面的能力，该平台将最新的生成式 AI 与代理工作流，与企业级治理、安全及运营功能有机融合。 Cloudera 亚太和日本区域高级副总裁 Remus Lim 表示：“在 IDC …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
September 12, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
GlobeNewswire
·
September 12, 2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 12 sept. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …
Oncotelic Therapeutics Highlights 2 Years of Clinical and Regulatory Advancements Across Late-Stage Pipeline
GlobeNewswire
·
September 12, 2025
AGOURA HILLS, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) ("OTLC" or the "Company"), a clinical-stage biopharmaceutical company developing transformative oncology and immunotherapy treatments, today …
Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
GlobeNewswire
·
September 12, 2025
Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review PARIS, France, September 12, 2025, 5:45 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage …